Search Results - "SENTZ, D. L"
-
1
Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats
Published in Cancer chemotherapy and pharmacology (1999)“…To define the plasma concentrations of butyrate achieved and the profile of plasma butyrate concentrations versus time in mice and rats treated with tributyrin…”
Get full text
Journal Article -
2
Pharmacokinetics and antitumor properties in tumor-bearing mice of an enediol analogue inhibitor of glyoxalase I
Published in Cancer chemotherapy and pharmacology (2000)“…The enediol analogue S-(N-p-chlorophenyl-N-hydroxycarbamoyl)glutathione (CHG) is a powerful, mechanism-based, competitive inhibitor of the…”
Get full text
Journal Article -
3
Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 mice
Published in Cancer chemotherapy and pharmacology (1994)“…We defined the pharmacokinetics of paclitaxel after i.v., i.p., p.o., and s.c. administration of 22.5 mg/kg to CD2F1 mice. Additional mice were studied after…”
Get full text
Journal Article -
4
Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer
Published in Cancer research (Chicago, Ill.) (01-11-1998)“…Interference with polyamine transport and biosynthesis has emerged as an important anticancer strategy involving polyamine analogues and specific inhibitors of…”
Get full text
Journal Article -
5
Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent
Published in Cancer chemotherapy and pharmacology (1999)“…Pc4 is a silicone phthalocyanine photosensitizing agent that is entering clinical trials. Studies were undertaken in mice to develop a suitable formulation and…”
Get full text
Journal Article -
6
Antitumor activity, distribution, and metabolism of 13-cis-retinoic acid as a single agent or in combination with tamoxifen in established human MCF-7 xenografts in mice
Published in Cancer chemotherapy and pharmacology (1999)“…The efficacy of 13-cis-retinoic acid (13-CRA) given as a single agent or in combination with tamoxifen (TAM) was determined in athymic nude mice bearing…”
Get full text
Journal Article -
7
Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1
Published in Cancer chemotherapy and pharmacology (01-04-2001)“…17-(Allylamino)-17-demethoxygeldanamycin (17AAG) is a benzoquinone ansamycin compound agent that has entered clinical trials. Studies were performed in mice…”
Get full text
Journal Article -
8
Synthesis and Antitumor Evaluation of a Highly Potent Cytotoxic DNA Cross-Linking Polyamine Analogue, 1,12-Diaziridinyl-4,9-diazadodecane
Published in Journal of medicinal chemistry (05-01-1996)“…A diaziridinylspermine analogue, 1,12-diaziridinyl-4,9-diazadodecane (NSC-667005), was synthesized as a bisalkylating agent with a polyamine backbone. DNA…”
Get full text
Journal Article -
9
In vitro metabolism by mouse and human liver preparations of halomon, an antitumor halogenated monoterpene
Published in Cancer chemotherapy and pharmacology (1997)“…To characterize the enzymes responsible for and metabolites produced from the metabolism of halomon, a halogenated monoterpene that is isolated from the red…”
Get full text
Journal Article -
10
Plasma pharmacokinetics, bioavailability, and tissue distribution in CD2F1 mice of halomon, and antitumor halogenated monoterpene isolated from the red algae Portieria hornemannii
Published in Cancer chemotherapy and pharmacology (1996)“…The purpose of the present study was to define the plasma pharmacokinetics, bioavailability, and tissue distribution in mice of halomon, a halogenated…”
Get full text
Journal Article -
11
Plasma pharmacokinetics and urinary excretion of the polyamine analogue 1, 19-bis(ethylamino)-5, 10, 15-triazanonadecane in CD2F1 mice
Published in Cancer chemotherapy and pharmacology (1996)“…The pharmacokinetics of 1, 19-bis(ethylamino)-5, 10, 15-triazanonadecane (BE-4-4-4-4) were determined in CD2F1 female mice after administration of i.v. bolus…”
Get full text
Journal Article